MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$18,900K
Unrealized gain (loss) on
marketable securities
-$1K
Net loss
-$18,899K
Loss before income
taxes
-$18,899K
Interest income, net
$647K
Loss from operations
-$19,546K
Total revenues
$303K
Total operating
expenses
$19,849K
General and
administrative
$5,626K
Research and development
$14,223K
Back
Back
Income Statement
source: myfinsight.com
Vistagen Therapeutics, Inc. (VTGN)
Vistagen Therapeutics, Inc. (VTGN)